Y-Intercept (HK)’s Immunocore IMCR Stock Holding History

Y-Intercept (HK)’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.02M	Buy	126,652 +91,725	+263%	+$2.71M	0.08%	356
2026 Q1	$1.05M	Sell	34,927 -13,260	-28%	-$429K	0.02%	1012
2025 Q4	$1.67M	Buy	48,187 +2,856	+6%	+$101K	0.04%	706
2025 Q3	$1.65M	Sell	45,331 -6,332	-12%	-$215K	0.04%	721
2025 Q2	$1.62M	Buy	+51,663	New	+$1.6M	0.04%	696
2024 Q3	–	Sell	-31,265	Closed	-$1.06M	–	1537
2024 Q2	$1.06M	Buy	+31,265	New	+$1.59M	0.06%	465

Other funds holding IMCR

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Y-Intercept (HK)'s IMCR Position: Q2 2026 in Review

Y-Intercept (HK) increased its Immunocore (IMCR) stake by 263% in Q2 2026, buying an estimated $2.71M and bringing the position to 126,652 shares worth $4.02M. The position accounts for 0.08% of the portfolio, ranked #356.

Y-Intercept (HK) first reported a position in IMCR in Q2 2024 and has held it in 6 quarters since. 13 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Y-Intercept (HK) held 126,652 shares of Immunocore worth $4.02M as of Q2 2026.
Y-Intercept (HK) bought 91,725 Immunocore shares in Q2 2026, an estimated $2.71M.
Immunocore made up 0.08% of Y-Intercept (HK)'s portfolio in Q2 2026, its #356 holding.
Y-Intercept (HK) first reported a position in Immunocore in Q2 2024 and has held it in 6 quarters since.
13 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.